Moreover we found that elevated RFC3 expression significantly correlates with several adverse prognostic factors in DLBCL, including age over 60, increased LDH levels, high IPI score, and advanced Ann Arbor stages (Stage III–IV), suggesting a role for RFC3 in the biological mechanisms underlying these features. The gene discussed is RFC3; the disease is diffuse large B-cell lymphoma.